Tekla Capital Management’s Rallybio RLYB Stock Holding History

Tekla Capital Management’s Portfolio RLYB Stock Details RLYB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$9.78M	Hold	215,883	–	–	0.38%	57
2023 Q1	$9.86M	Hold	215,883	–	–	0.38%	55
2022 Q4	$11.3M	Sell	215,883 -1,733	-0.8%	-$102K	0.43%	54
2022 Q3	$25.2M	Sell	217,616 -23,774	-10%	-$2.12M	1.03%	29
2022 Q2	$14.6M	Sell	241,390 -32,986	-12%	-$2.48M	0.57%	46
2022 Q1	$15.3M	Sell	274,376 -14,208	-5%	-$1.18M	0.54%	51
2021 Q4	$20.4M	Hold	288,584	–	–	0.66%	43
2021 Q3	$37.6M	Buy	+288,584	New	+$33.8M	1.21%	24

Other funds holding RLYB

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

CPX

Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tekla Capital Management's RLYB Position: Q2 2023 in Review

Tekla Capital Management held its Rallybio (RLYB) position steady in Q2 2023 at 215,883 shares worth $9.78M. The position accounts for 0.38% of the portfolio, ranked #57.

Tekla Capital Management first reported a position in RLYB in Q3 2021 and has held it in 8 quarters since. The position peaked at $37.6M in Q3 2021. 59 funds tracked by Wall St. Rank hold RLYB as of Q2 2023.

Tekla Capital Management held 215,883 shares of Rallybio worth $9.78M as of Q2 2023.
Tekla Capital Management left its Rallybio share count unchanged in Q2 2023.
Rallybio made up 0.38% of Tekla Capital Management's portfolio in Q2 2023, its #57 holding.
Tekla Capital Management first reported a position in Rallybio in Q3 2021 and has held it in 8 quarters since.
Tekla Capital Management's Rallybio position peaked at $37.6M in Q3 2021.
59 funds tracked by Wall St. Rank held Rallybio as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.